Literature DB >> 19946436

Good stress, bad stress--the delicate balance in the vasculature.

Kirstin Wingler1, Harald H H W Schmidt.   

Abstract

BACKGROUND: Radicals have important physiological functions, for example, in immune defense and vasoprotection. However, they are also potentially dangerous waste products of cellular metabolism and they can contribute to the development of many different diseases.
METHOD: Selective literature review.
RESULTS: The scientific understanding of radicals has not yet led to any therapeutic application. For many years, scavenging already formed radicals with antioxidants was considered to be the most promising therapeutic approach, but clinical trials based on this principle have yielded mostly negative results. Thus, entirely new approaches are needed. The goal should be to prevent the formation of harmful radicals, or to treat radical-related damage if it has already occurred. New diagnostic tools have the potential to identify those patients that are most likely to benefit from this form of treatment, as well as to document its success.
CONCLUSIONS: A new generation of cardiovascular drugs is being developed for the prevention or the mechanism-based treatment of vascular damage caused by oxidative stress. This new therapy should go hand in hand with new diagnostics, in accordance with the principle of individualized medicine.

Entities:  

Keywords:  antioxidants; nitric oxide; oxidative stress; radicals; vascular diagnostics

Mesh:

Substances:

Year:  2009        PMID: 19946436      PMCID: PMC2780706          DOI: 10.3238/arztebl.2009.0677

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  46 in total

1.  L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial.

Authors:  Steven P Schulman; Lewis C Becker; David A Kass; Hunter C Champion; Michael L Terrin; Sandra Forman; Kavita V Ernst; Mark D Kelemen; Susan N Townsend; Anne Capriotti; Joshua M Hare; Gary Gerstenblith
Journal:  JAMA       Date:  2006-01-04       Impact factor: 56.272

Review 2.  NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential.

Authors:  Oleg V Evgenov; Pál Pacher; Peter M Schmidt; György Haskó; Harald H H W Schmidt; Johannes-Peter Stasch
Journal:  Nat Rev Drug Discov       Date:  2006-09       Impact factor: 84.694

3.  Do we still need organic nitrates?

Authors:  Thomas Münzel; Philip Wenzel; Andreas Daiber
Journal:  J Am Coll Cardiol       Date:  2007-03-23       Impact factor: 24.094

4.  Decision analysis supports the paradigm that indiscriminate supplementation of vitamin E does more harm than good.

Authors:  Yedidya Dotan; Ilya Pinchuk; Dov Lichtenberg; Moshe Leshno
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-03-12       Impact factor: 8.311

5.  Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels.

Authors:  Johannes-Peter Stasch; Peter M Schmidt; Pavel I Nedvetsky; Tatiana Y Nedvetskaya; Arun Kumar H S; Sabine Meurer; Martin Deile; Ashraf Taye; Andreas Knorr; Harald Lapp; Helmut Müller; Yagmur Turgay; Christiane Rothkegel; Adrian Tersteegen; Barbara Kemp-Harper; Werner Müller-Esterl; Harald H H W Schmidt
Journal:  J Clin Invest       Date:  2006-09       Impact factor: 14.808

6.  The emerging biology of the nitrite anion.

Authors:  Mark T Gladwin; Alan N Schechter; Daniel B Kim-Shapiro; Rakesh P Patel; Neil Hogg; Sruti Shiva; Richard O Cannon; Malte Kelm; David A Wink; Michael Graham Espey; Edward H Oldfield; Ryszard M Pluta; Bruce A Freeman; Jack R Lancaster; Martin Feelisch; Jon O Lundberg
Journal:  Nat Chem Biol       Date:  2005-11       Impact factor: 15.040

Review 7.  Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis.

Authors:  Goran Bjelakovic; Dimitrinka Nikolova; Lise Lotte Gluud; Rosa G Simonetti; Christian Gluud
Journal:  JAMA       Date:  2007-02-28       Impact factor: 56.272

Review 8.  The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology.

Authors:  Karen Bedard; Karl-Heinz Krause
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

9.  Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment.

Authors:  Zachary T Schafer; Alexandra R Grassian; Loling Song; Zhenyang Jiang; Zachary Gerhart-Hines; Hanna Y Irie; Sizhen Gao; Pere Puigserver; Joan S Brugge
Journal:  Nature       Date:  2009-08-19       Impact factor: 49.962

10.  The eNOS enhancer AVE 9488: a novel cardioprotectant against ischemia reperfusion injury.

Authors:  S Frantz; A Adamek; D Fraccarollo; J Tillmanns; J D Widder; C Dienesch; A Schäfer; A Podolskaya; M Held; H Ruetten; G Ertl; J Bauersachs
Journal:  Basic Res Cardiol       Date:  2009-06-23       Impact factor: 17.165

View more
  4 in total

1.  Correspondence (letter to the editor): Lucid scientific analysis.

Authors:  Jens E Altwein
Journal:  Dtsch Arztebl Int       Date:  2010-04-02       Impact factor: 5.594

2.  Correspondence (letter to the editor): Disputed meta-analyses.

Authors:  M P Look
Journal:  Dtsch Arztebl Int       Date:  2010-04-02       Impact factor: 5.594

3.  Correspondence (letter to the editor): Nature as the optimal organizer.

Authors:  Udo Böhm
Journal:  Dtsch Arztebl Int       Date:  2010-04-02       Impact factor: 5.594

Review 4.  Deleterious effects of reactive metabolites.

Authors:  Sabry M Attia
Journal:  Oxid Med Cell Longev       Date:  2010 Jul-Aug       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.